Abstract
The authors report results of an 8-week, open trial of desipramine in 42 patients with DSM-III-R dysthymia with a concurrent diagnosis of major depression ("double" depression) and 33 patients with dysthymia who had no other depressive diagnosis ("pure" dysthymia). Either complete or partial remission was achieved by 70% of the patients with "pure" dysthymia. This compared favorably with but was not significantly different from results in the "double" depression group.
Original language | English |
---|---|
Pages (from-to) | 1079-1080 |
Number of pages | 2 |
Journal | American Journal of Psychiatry |
Volume | 151 |
Issue number | 7 |
State | Published - Jul 1994 |